Cytokines in autoimmune disorders

International Reviews of Immunology

Volumn 17, Issue 1-4, 1998, Pages 217-228

  Feldmann, Marc ^a   Brennan, Fionula M ^a   Maini, Ravinder ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Autoimmunity; Cytokines; Rheumatoid arthritis; TNF (tumour necrosis factor)

Indexed keywords

AUTOIMMUNE DISEASE; CROHN DISEASE; CYTOKINE; CYTOKINE RECEPTOR; FIBROSIS; GAMMA INTERFERON; INFLAMMATION; MOLECULAR CLONING; PATHOGENESIS; RHEUMATOID ARTHRITIS; TUMOR NECROSIS FACTOR ALPHA;

EID: 0032426550     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.3109/08830189809084493     Document Type: Article

References (41)

1. Allison, J., Malcolm, L , Chosich, N. and Miller, J.F.A.P. (1992). Inflammation but not autoimmunity occurs in transgenic mice expressing constitutive levels of IL-2 in islet β cells. Eur. J. Immunol., 22, 1115-21.
2. Arend, W P. (1993). Interleukin-J receptor antagonist. Adv. Immunol, 54, 167-227.
3. Bendtzen, K., Morling, N., Fomsgaard, A., Svenson, M., Jakobsen, B., Odum, N. and Svejgaard, A (1988). Association between HLA-DR2 and productio of tumour necrosis factor α and interleukin 1 by mononuclear cells activated by lipopoly-saccharide. Scand. J. Immunol., 28, 599-606.
4. Bottazzo, G F., Pujol-Borrell, R., Hanafusa, T. and Feldmann, M. (1983). Hypothesis: Role of aberrant HLA-DR expression and antigen presentation in the induction of endocrine autoimmunity. Lancet, ii, 1115-9.
5. Brennan, F.M., Chantry, D., Jackson, A, Maini, R. and Feldmann, M. (1989). Inhibitory effect of TNF α antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet, 2, 244-7.
6. Brennan, F.M and Feldmann, M.F. (1996) Cytokins in Autoimmunity RG Landes, Austin, Texas.
7. Bresnihan, B., Lookbaugh, J., Witt, K. and Musikic, P. (1996). Treatment with recombinant human interleukin-1 receptor antagonist (rhIL-1ra) in rheumatoid arthritis (RA): results of a randomized double-blind, placebo-controlled multicenter trial. Arthritis Rheum., 39, S282.
8. Bresnihan, B., Mulherin, D. and FitzGerald, O. (1995). Synovial pathology and articular erosion in rheumatoid arthritis. Rheumatology in Europe, 24 (S), 158-60.
9. Buchan, G., Barrett, K., Turner, M., Chantry, D., Maini, R.N. and Feldmann, M. (1988). Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1α. Clin. Exp. Immunol., 73, 449-55.
10. Burman, P., Totterman, T.H., Oberg, K. and Anders Karlsson, F. (1986). Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon. J. Clin. Endocrinol Metab., 63, 1086-90.
11. Butler, D.M., Maini, R.N., Feldmann, M. and Brennan, F.M. (1995). Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti-TNFα antibody with the IL-1 receptor antagonist. Eur. Cytokine. Netw., 6, 225-30.
12. Cope, A.P., Aderka, D., Doherty, M., Engelmann, H., Gibbons, D., Jones, A.C., Brennan, F.M., Maini, R.N., Wallach, D. and Feldmann, M. (1992). Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum., 35, 1160-9.
13. Cutulo, M., Kirkham, B., Bologna, C., Sony, J., Scott, D., Brooks, P., Forre, O., Jain, R., Markensen, J., Seebold, J., Sturrock, R., Veys, E., Edwards, J., Zaug, M., Durrwell, L., Bisschops, C., Milnarik, P. and Baudin Mond van der Auwera, P. (1996). Loading/ maintenance doses approach to neutralization of TNF by lenercept in patients with rheumatoid arthritis treated for 3 months: results of a double blind placebo controlled phase II trial. Arthritis Rheum., 39 Suppl. 9, S243.
14. Elliott, M.J., Maini, R.N., Feldmann, M., Kalden, J.R., Antoni, C., Smolen, J.S., Leeb, B., Breedveld, F.C., Macfarlane, J.D., Bijl, H. and Woody, J.N. (1994a). Randomised double blind comparison of a chimaeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet, 344, 1105-10.
15. Elliott, M.J., Maini, R.N., Feldmann, M., Long-Fox, A., Charles, P., Bijl, H. and Woody, J N. (1994b). Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis. Lancet, 344, 1125-7.
16. Elliott, M.J., Maini, R.N., Feldmann, M., Long-Fox, A., Charles, P., Katsikis, P., Brennan, F.M., Walker, J., Bijl, H., Ghrayeb, J, and Woody, J. (1993). Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to TNFα. Arthritis Rheum., 36, 1681-90.
17. Fava, R., Olsen, N., Keski-Oja, J., Moses, H. and Pincus, T. (1989). Active and latent forms of transforming growth factor β activity in synovial effusions. J. Exp. Med., 169, 291-6.
18. Feldmann, M , Brennan, F.M. and Maini, R.N. (1996). Role of cytokines in rheumatoid arthritis. Annu Rev Immunol, 14, 397-440.
19. Fong, Y., Tracey, K J., Moldawer, L.L., Hesse, D.G., Manogue, K.B., Kenney, J.S., Lee, A.T., Kuo, G.C., Allison, A.C., Lowry, S F. and Cerami, A. (1989). Antibodies to cachectin/tumor necrosis factor reduce 1β and interleukin 6 appearance during lethal bacteremia. J. Exp. Med., 170, 1627-33.
20. Gregersen, P.K., Silver, J. and Winchester, R.J. (1987). The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum., 30, 1205-13.
21. Gu, D.-L , Wogensen, L., Calcutt, N A., Xia, C.-Y., Zhu, S -M., Merlie, J.P., Fox, H.S., Lindstrom, J., Powell, H.C. and Sarvetnick, N. (1995). Myastenia gravis-like syndrome Induced by expression of interferon-gamma in the neuromuscular junction. Journal of Experimental Medicine, 181, 547-57.
22. Hanafusa, T., Pujol-Borrell, R., Chiovato, L., Russell, R.C.G., Doniach, D. and Bottazzo, G.F. (1983). Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet, ii, 1111-5.
23. Haworth, C., Brennan, F.M., Chantry, D., Turner, M., Maini, R.N. and Feldmann, M. (1991). Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-α Eur. J. Immunol., 21, 2575-9.
24. Jacob, C.O., Fronek, Z., Lewis, G.D., Koo, M., Hansen, J.A. and McDevitt, H.O. (1990). Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: Relevance to genetic predisposition to systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA, 87, 1233-7.
25. Jacob, C.O. and McDevitt, H.O. (1988). Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature, 331, 356-8.
26. Jacob, C.O., van der Meide, P.H. and McDevitt, H.O. (1987). In vivo treatment of (NZB × NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J. Exp. Med., 166, 798-803
27. Janossy, G., Panayai, G., Duke, O., Bofill, M., Poulter, L.W. and Goldstein, G (1981). Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet, ii, 839-42.
28. Katsikis, P., Chu, C.Q., Brennan, F M, Maini, R.N. and Feldmann, M. (1994). Immunoregulatory role of interleukin 10 (IL-10) in rheumatoid arthritis. J. Exp. Med., 179, 1517-27.
29. Klareskog, L., Forsum, U., Scheynius, A , Kabelitz, D. and Wigzell, H. (1982). Evidence in support of a self perpetuating HLA-DR dependent delayed type cell reaction in rheumatoid arthritis. Proc. Natl. Acad. Sci USA, 72, 3632-6.
30. Maini, R.N., Elliott, M.J., Charles, P.J. and Feidmann, M. (1994). Immunological intervention reveals reciprocal roles for TNFα and IL-10 in rheumatoid arthritis and SLE, Springer Semin Immunopathol., 16, 327-36.
31. McDowell, T.L , Symons, J.A., Ploski, R., Forre, O. and Duff, G.W. (1995). A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism Arthritis Rheum., 38, 221-8.
32. Mosmann, T.R. and Coffman, R.L. (1989). Th2 and Th2 cells: Different patterns of Iymphokine secretion lead to different functional properties. Annu. Rev. Immunol., 7, 145-73
33. Oppenheim, J.J. and Saklatvala, J. (1993). Cytokines and their receptors. In Clinical applications of cytokines: role in pathogenesis. diagnosis and therapy (eds J.J. Oppenheim, J.L. Rossio and A.J.H. Gearing), pp. 3-15 Oxford University Press, Oxford.
34. Sarvetnick, N., Shizuru, J., Liggitt, D., Martin, L., McIntyre, B., Gregory, A., Parslow, T. and Stewart, T. (1990). Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ. Nature, 346, 844-7.
35. Saxne, T., Palladino, M.A., Jr., Heinegard, D., Talal, N. and Wollheim, F.A. (1988). Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum Arthritis Rheum., 31, 1041-5.
36. Silman, A.J , MacGregor, A.J., Thomson, W., Holligan, S., Carthy, D., Farhan, A. and Ollier, W.E.R. (1993), Twin concordance rates for rheumatoid arthritis: Results from a nationwide study. Br. J. Rheumatol., 32, 903-7.
37. Stewart, T.A., Hultgren, B., Huagn, X., Pitts-Meek, S., Hully, J. and McLachlan, N.J. (1993). Induction of type-1 diabetes by interferon-a in transgenic mice. Science, 260, 1942-7.
38. Williams, R.O., Mason, L.J., Feldmann, M. and Maini, R.N. (1994). Synergy between anti-CD4 and anti-TNF in the amelioration of established collagen-induced arthritis. Proc. Natl. Acad. Sci. USA, 91, 2762-6.
39. Wilson, A.G., Gordon, C., di Giovine, F.S., de Vries, N., van de Putte, L.B.A., Emery, P. and Duff, G.W. (1994). A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur. J. Immunol., 24, 191-5.
40. Wood, N.C., Dickens, E., Symons, J.A, and Duff, G.W. (1992). In situ hybridization of interleukin-1 in CD 14-positive cells in rheumatoid arthritis. Clin. Immunol. Immunopathol., 62, 295-300.
41. Yssel, H., de Waal Malefyt, R , Roncarolo, M.G., Abrams, J.S., Lahesmaa, R., Spits, H. and de Vries, J.E. (1992). IL-10 is produced by subsets of human CD4+ TS- T cell clones and peripheral blood T cells. J. Immunol., 149, 2378-84.